Comparison of left ventricular mass and geometric remodeling in treated and untreated men and women > 50 years of age with systemic hypertension

Miguel Zabalgoitia, S. Noor Ur Rahman, William E Haley, John Amerena, Lisa Krause, Lori Oneschuk, Steven Yarows, Carla Yunis, Charles Lucas

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To investigate the effects of left ventricular (LV) mass and geometry in hypertensive patients >50 years of age, 540 men and women were divided into controlled, uncontrolled, and untreated groups. The high prevalence of concentric LV hypertrophy in postmenopausal women, despite medical therapy, emerged as potentially important and underrecognized factor of their cardiovascular risk.

Original languageEnglish (US)
Pages (from-to)648-651
Number of pages4
JournalAmerican Journal of Cardiology
Volume80
Issue number5
DOIs
StatePublished - Sep 1 1997
Externally publishedYes

Fingerprint

Hypertension
Left Ventricular Hypertrophy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of left ventricular mass and geometric remodeling in treated and untreated men and women > 50 years of age with systemic hypertension. / Zabalgoitia, Miguel; Rahman, S. Noor Ur; Haley, William E; Amerena, John; Krause, Lisa; Oneschuk, Lori; Yarows, Steven; Yunis, Carla; Lucas, Charles.

In: American Journal of Cardiology, Vol. 80, No. 5, 01.09.1997, p. 648-651.

Research output: Contribution to journalArticle

Zabalgoitia, Miguel ; Rahman, S. Noor Ur ; Haley, William E ; Amerena, John ; Krause, Lisa ; Oneschuk, Lori ; Yarows, Steven ; Yunis, Carla ; Lucas, Charles. / Comparison of left ventricular mass and geometric remodeling in treated and untreated men and women > 50 years of age with systemic hypertension. In: American Journal of Cardiology. 1997 ; Vol. 80, No. 5. pp. 648-651.
@article{9a747a28b2a54f4aadb9d2aaf68dcf3a,
title = "Comparison of left ventricular mass and geometric remodeling in treated and untreated men and women > 50 years of age with systemic hypertension",
abstract = "To investigate the effects of left ventricular (LV) mass and geometry in hypertensive patients >50 years of age, 540 men and women were divided into controlled, uncontrolled, and untreated groups. The high prevalence of concentric LV hypertrophy in postmenopausal women, despite medical therapy, emerged as potentially important and underrecognized factor of their cardiovascular risk.",
author = "Miguel Zabalgoitia and Rahman, {S. Noor Ur} and Haley, {William E} and John Amerena and Lisa Krause and Lori Oneschuk and Steven Yarows and Carla Yunis and Charles Lucas",
year = "1997",
month = "9",
day = "1",
doi = "10.1016/S0002-9149(97)00443-8",
language = "English (US)",
volume = "80",
pages = "648--651",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Comparison of left ventricular mass and geometric remodeling in treated and untreated men and women > 50 years of age with systemic hypertension

AU - Zabalgoitia, Miguel

AU - Rahman, S. Noor Ur

AU - Haley, William E

AU - Amerena, John

AU - Krause, Lisa

AU - Oneschuk, Lori

AU - Yarows, Steven

AU - Yunis, Carla

AU - Lucas, Charles

PY - 1997/9/1

Y1 - 1997/9/1

N2 - To investigate the effects of left ventricular (LV) mass and geometry in hypertensive patients >50 years of age, 540 men and women were divided into controlled, uncontrolled, and untreated groups. The high prevalence of concentric LV hypertrophy in postmenopausal women, despite medical therapy, emerged as potentially important and underrecognized factor of their cardiovascular risk.

AB - To investigate the effects of left ventricular (LV) mass and geometry in hypertensive patients >50 years of age, 540 men and women were divided into controlled, uncontrolled, and untreated groups. The high prevalence of concentric LV hypertrophy in postmenopausal women, despite medical therapy, emerged as potentially important and underrecognized factor of their cardiovascular risk.

UR - http://www.scopus.com/inward/record.url?scp=0030987471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030987471&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(97)00443-8

DO - 10.1016/S0002-9149(97)00443-8

M3 - Article

VL - 80

SP - 648

EP - 651

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -